Gibson Matthew, Nguyen Phuoc Anh Anne, Casserly Elizabeth Ann, Efird Leigh E, Kuester Melanie K, Masters Patricia, Miller Luke, Lewis Daniel A, Weber Robert J
Novant Health, Winston-Salem, NC, USA.
The University of Texas MD Anderson Cancer Center, Houston, USA.
Hosp Pharm. 2021 Apr;56(2):124-132. doi: 10.1177/0018578719868408. Epub 2019 Aug 16.
Opioid use is classified as an epidemic by many due to the impact of these medications on society. Federal and state laws for prescribing and dispensing opioids have changed rapidly in a short period of time to hopefully balance proper pain control with their use. Pharmacy directors must be informed of these rapid changes to effectively work as part of any opioid stewardship team. The objective of this study was to provide foundational leadership guidance to pharmacy directors on current opioid legislation, literature, and best practices to assist in improving opioid use. A review of the literature from 2003 to the present was conducted along with collating important up to date resources and other publications that provide foundational information to help support a comprehensive management of opioid use. A summary of these data has been collated into an easy to use table and summarized throughout this article. The information provided in this article helps to properly inform pharmacy leaders to the resources available to improve the prescribing, dispensing, and monitoring of opioids and alternatives.
由于这些药物对社会的影响，许多人将阿片类药物的使用归类为一种流行病。在短时间内，联邦和州关于阿片类药物处方和配药的法律迅速变化，以期在其使用与适当的疼痛控制之间取得平衡。药房主任必须了解这些快速变化，以便作为任何阿片类药物管理团队的一员有效地开展工作。本研究的目的是为药房主任提供关于当前阿片类药物立法、文献和最佳实践的基础领导指导，以协助改善阿片类药物的使用。对2003年至今的文献进行了综述，并整理了重要的最新资源和其他出版物，这些资源提供了基础信息，有助于支持对阿片类药物使用的全面管理。这些数据的总结已整理成一个易于使用的表格，并在本文中进行了总结。本文提供的信息有助于让药房领导者正确了解可用于改善阿片类药物及替代药物的处方、配药和监测的资源。
